Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FDQZH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,698
Award facts
- Contract value 100% obligated
- $13,697.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 21, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units valued at $13,697.84. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a specific pharmaceutical product pull under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract contains no set-aside designation and will be performed in Park Ridge, Illinois, where the woman-owned small business pharmaceutical wholesaler is headquartered.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its $499,999,999 Indefinite Delivery Contract with the DLA under the SPE2DB program, which remains valid through November 2026. This existing contract vehicle enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military healthcare facility needs nationwide. The company's extensive federal procurement portfolio includes delivery of branded and generic prescription medications, biologics, and specialized medical supplies, positioning it as a consistent and approved vendor for Department of Defense pharmaceutical distribution requirements.
Quick answers
Who was awarded contract SPE2DB25FDQZH?
SPE2DB25FDQZH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FDQZH worth?
The government has obligated $13,698 on SPE2DB25FDQZH.
Is contract SPE2DB25FDQZH an order under another contract?
Yes. SPE2DB25FDQZH is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQZH competed?
The extent of competition for SPE2DB25FDQZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award